Tyler Reese MD, AAHIVS
Medical Director, Inpatient Addiction Consult Team, UI Health
Assistant Professor of Clinical Medicine
Academic Internal Medicine, Department of Medicine
College of Medicine. University of Illinois Chicago
he/him
Contact
Office Phone:
(866) 600-2273
Mailing Address:
1740 West Taylor Street, MC 718 Chicago, IL 60612
Related Sites:
About
Tyler Reese, MD, AAHIVS, grew up in Cleveland, Ohio, and pursued his Bachelor of Science in Environmental Public Health at The Ohio State University, where he developed his interest in addiction medicine and public health as an HIV/STI test counselor. Dr. Reese received his medical degree from Loyola University Chicago Stritch School of Medicine and completed his residency in Internal Medicine at the University of Colorado as a member of its renowned Primary Care Track at Denver Health Medical Center. Dr. Reese completed his Addiction Medicine fellowship at Rush University Medical Center and is an AAHIVM HIV Specialist. Dr. Reese was the recipient of an NIH National Heart, Lung, and Blood Institute T35 Research Grant for his published work in obesity and global public health. Dr. Reese also co-authored the first published case report of an outbreak of medetomidine-associated opioid overdoses in Chicago, Illinois, in May 2024. Dr. Reese is currently serving as a Sub-Investigator for Merck’s Phase 3 EXPrESSIVE-11 trial (MK-8527-011, NCT 07044297) evaluating the efficacy and safety of MK-8527 oral once-monthly as HIV-1 Preexposure Prophylaxis. In addition, Dr. Reese serves as the UIC co-lead for the Adolescent Trials Network (ATN) for HIV/AIDS Interventions. His research activities include ATN 173, a study evaluating the effectiveness of doxycycline post-exposure prophylaxis (Doxy-PEP) in preventing bacterial sexually transmitted infections among adolescent and young adult females, and ATN 166, which is evaluating an integrated mobile health (mHealth) and telehealth intervention to improve PrEP engagement and adherence among young queer men. Dr. Reese was awarded the 2025 Ruth Fox Scholarship and the American Society of Addiction Medicine’s AMAC Scholarship in recognition of his addiction advocacy and policy work. Dr. Reese currently serves as the Medical Director of the Inpatient Addiction Consult Team at UI Health and as an Assistant Professor of Clinical Medicine at the University of Illinois Chicago.
For more information, please visit Dr. Tyler Reese's Department of Medicine Faculty Profile.
Interests
Addiction Medicine, HIV Medicine, Stimulant Use, LGBTQIA Health, and Hepatitis C
Projects
EXPrESSIVE-11 trial (MK-8527-011, NCT 07044297)
Dr. Reese is currently serving as a Sub-Investigator for Merck’s Phase 3 EXPrESSIVE-11 trial (MK-8527-011, NCT 07044297) evaluating the efficacy and safety of MK-8527 oral once-monthly as HIV-1 Preexposure Prophylaxis.
HPTN 115/ATN 173
Dr. Reese serves as the UIC co-lead for the Adolescent Trials Network (ATN) for HIV/AIDS Interventions. His research activities include ATN 173, a study evaluating the effectiveness of doxycycline post-exposure prophylaxis (Doxy-PEP) in preventing bacterial sexually transmitted infections among adolescent and young adult females
ATN 166
Dr. Reese serves as the UIC co-lead for the Adolescent Trials Network (ATN) for HIV/AIDS Interventions. His research activities include ATN 166, which is evaluating an integrated mobile health (mHealth) and telehealth intervention to improve PrEP engagement and adherence among young queer men.
Publications
-
Nayani, Z., Reese, T.O., Armstrong, A., Walker, A., Tani, F., Fitzgerald, R. (2025). Medetomidine-Associated Opioid Overdoses in Chicago, Illinois: A Report of 3 Cases. Journal of addiction medicine, 19(4), 497–500. https://doi.org/10.1097/ADM.0000000000001500
Choo-Kang, C., Reese, T. O., Micklesfield, L. K., Bovet, P., Bedu-Addo, K., Forrester, T., Gilbert, J. A., Goedecke, J. H., Plange-Rhule, J., Lambert, E. V., Layden, B. T., Rae, D. E., Viswanathan, B., Luke, A., & Dugas, L. (2024). Silhouette showcards confirm altered obesity associated body image perception in international cohort study of African-origin populations. BMJ open, 14(3), e065498. https://doi.org/10.1136/bmjopen-2022-065498
Reese, T. O., Bovet, P., Choo-Kang, C., Bedu-Addo, K., Forrester, T., Gilbert, J. A., Goedecke, J. H., Lambert, E. V., Layden, B. T., Micklesfield, L. K., Plange-Rhule, J., Rae, D., Viswanathan, B., Luke, A., & Dugas, L. R. (2022). Utility of silhouette showcards to assess adiposity in three countries across the epidemiological transition. PLOS global public health, 2(5), e0000127. https://doi.org/10.1371/journal.pgph.0000127